4//SEC Filing
SCHIERMEIER ANDREW 4
Accession 0000899243-20-006973
CIK 0001652130other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:27 PM ET
Size
8.9 KB
Accession
0000899243-20-006973
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Award
Stock Option (Right to Buy)
2020-01-03+15,000→ 15,000 totalExercise: $13.48From: 2020-01-03Exp: 2027-01-02→ Common Stock (15,000 underlying) - Award
Stock Option (Right to Buy)
2020-03-02+135,000→ 135,000 totalExercise: $13.40Exp: 2030-03-01→ Common Stock (135,000 underlying)
Holdings
- 10,316
Common Stock
Footnotes (3)
- [F1]This amount includes 1,672 shares acquired under the NTLA Employee Stock Purchase Plan (912 shares purchased on 6/30/2019 and 760 shares purchased on 12/31/2019).
- [F2]On January 3, 2017, the reporting person was granted an option to purchase 15,000 shares of common stock. The option vested based on the satisfaction of certain performance criteria. The performance criteria was met, resulting in the vesting of option as to 15,000 shares.
- [F3]This option was granted on March 2, 2020 with respect to 135,000 shares of Common Stock, with 25% vesting on January 1, 2021 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001738456
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:27 PM ET
- Size
- 8.9 KB